Astellas Institute for Regenerative Medicine
id:
astellas-institute-for-regenerative-medicine-210-2343934
title:
Astellas Institute for Regenerative Medicine
text:
Astellas Institute for Regenerative Medicine is a subsidiary of Astellas Pharma located in Marlborough, Massachusetts, US, developing stem cell therapies with a focus on diseases that cause blindness. It was formed in 1994 as a company named Advanced Cell Technology, Incorporated (ACT), which was renamed to Ocata Therapeutics in November 2014. In February 2016 Ocata was acquired by Astellas for $379 million USD.
brand slug:
wiki
category slug:
encyclopedia
description:
Subsidiary of Astellas Pharma
original url:
https://en.wikipedia.org/wiki/Astellas_Institute_for_Regenerative_Medicine
date created:
2007-09-24T02:01:33Z
date modified:
2024-09-11T17:26:22Z
main entity:
{"identifier":"Q4686139","url":"https://www.wikidata.org/entity/Q4686139"}
image:
fields total:
13
integrity:
15